We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




NIH Extends Collaboration for HIV Diagnostics

By HospiMedica staff writers
Posted on 09 Apr 2007
Human immunosuppressive virus (HIV) diagnostics are important to maintaining the safety of the blood supply through donor screening and by providing early diagnosis and monitoring of HIV infection so that patients may benefit from early treatment regimens.

The U.S. More...
National Institutes of Health (NIH; Bethesda, MD, USA), an agency of the U.S. Department of Health and Human Services, and Institut Pasteur (IP; Paris, France), a private non-profit foundation, announced an agreement to extend their long-standing collaboration in health research and the management of inventions arising from this research. These two institutions have been leaders and collaborators in the field of HIV/AIDS research for more than 20 years. The extended agreement will initially facilitate the patenting and licensing of a large portfolio of intellectual property held by NIH and IP in the field of HIV-1 diagnostics. Additional long-term public health benefits are expected as the agreement provides a new framework for further support and encouragement of collaborative research in a variety of areas by leading scientists at both the NIH and IP.

To date, effective HIV-1 diagnostic test kits based upon technology licensed from IP and NIH has been distributed worldwide by many companies, saving millions of lives. As the science of understanding the HIV-1 virus has progressed, new technologies arising from the laboratories of IP and NIH and subsequently developed by diagnostics companies now allow these tests to be provided with increased sensitivity and specificity but at a lower cost.

According to the latest figures published an estimated 39.5 million people are living with HIV. There were 4.3 million new infections in 2006 with 2.8 million (65%) of these occurring in sub-Saharan Africa and important increases in Eastern Europe and Central Asia, where there are some indications that infection rates have risen by more than 50% since 2004. In 2006, 2.9 million people died of AIDS-related illnesses.

Institut Pasteur is dedicated to the prevention and treatment of diseases through research, education, and public health activities. A large part of Institut Pasteur's research activities is devoted to infectious diseases with important efforts on AIDS research.


Related Links:
U.S. National Institutes of Health
Institut Pasteur

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.